Tirz: Dual Agonist

$59.99 - $119.99

Clear
Add to wishlist
Share
🚚 Same Day Shipping
All orders placed before 12pm EST ship same day.
📦 On Time Delivery
Multiple shipping options available.
💬 US Based Support
Need help? We're here to help.

    TIRZ-Dual Agonist Research & References

    Sources & References

    Peer-reviewed research and scientific references related to Tirzepatide (TIRZ).

    NEW ENGLAND JOURNAL OF MEDICINE

    Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

    2022
    Jastreboff AM, Aronne LJ, Ahmad NN, et al.

    View Source ↗

    NEW ENGLAND JOURNAL OF MEDICINE

    Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)

    2025
    Aronne LJ, Horn DB, et al.

    View Source ↗

    THE LANCET DIABETES & ENDOCRINOLOGY

    Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, in People With Type 2 Diabetes

    2023
    Rosenstock J, Wysham C, Frías JP, et al.

    View Source ↗

    DIABETES, OBESITY AND METABOLISM

    Results From the SURMOUNT-1 Study: Health-Related Quality of Life Outcomes

    2025
    Gudzune KA, et al.

    View Source ↗

    Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been extensively studied in research involving metabolic regulation, body composition, glucose homeostasis, and obesity-related outcomes. These references are provided for educational and scientific purposes only.

    GLP-1

    Dual GIP and GLP-1 Receptor Agonist – Advanced Research Peptide


    Overview

    GLP-1 dual agonist by Helixion Labs is a premium-quality dual agonist peptide targeting both the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors.
    This peptide is studied for its potential role in metabolic and endocrine research, particularly in exploring mechanisms of glucose regulation, insulin sensitivity, and energy balance.

    Produced under GMP-compliant conditions and verified for ≥99% purity (HPLC), Helixion Labs’ GIP Dual Agonist ensures exceptional reliability and consistency across laboratory applications. Its lyophilized formulation enhances stability and shelf life, supporting accurate and reproducible results.


    Key Features

    • ≥99% purity verified by HPLC

    • Dual-action GIP and GLP-1 receptor analog

    • Stable lyophilized peptide for extended storage

    • Manufactured in a GMP-compliant facility

    • Ideal for studies on insulin regulation, energy metabolism, and peptide signaling pathways


    Specifications

    Specification Detail
    Molecular Formula C₂₂₅H₃₄₈N₄₈O₆₈
    Molecular Weight 4813.5 g/mol
    Form Lyophilized powder
    Quantity 30mg vial
    Storage Conditions Store frozen at –20°C. Once reconstituted, refrigerate at 2–8°C and use within 30 days.

    Disclaimer

    For laboratory research use only.
    Not for human consumption, medical, or veterinary use.

    Size

    5mg, 30mg, 10mg

    Reviews

    There are no reviews yet.

    Be the first to review “Tirz: Dual Agonist”

    Your email address will not be published. Required fields are marked *